CD20 +

About

Biomarker type: Protein expression

Marker: CD20

Unit: status

Equality: =

Value: Positive

Mappings
View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations Biomarkers Cancer types Therapies
FDA (1) HSE (4) CD20 + Non-Hodgkin Lymphoma Rituximab
FDA (1) HSE (2) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Prednisolone, Rituximab, Vincristine
EMA (1) FDA (1) HSE (3) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine
FDA (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Fludarabine, Mitoxantrone, Rituximab
FDA (2) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Burkitt Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Mature B-Cell Neoplasms Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Chronic Lymphocytic Leukemia Cyclophosphamide, Fludarabine, Rituximab
EMA (1) CD20 + Diffuse Large B-Cell Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) CD20 + Non-Hodgkin Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) CD20 + Burkitt Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
HSE (1) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Chlorambucil, Mitoxantrone, Prednisolone, Rituximab
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Interferon Alpha, Prednisolone, Rituximab
HSE (4) CD20 + Follicular Lymphoma Rituximab
HSE (2) CD20 + Follicular Lymphoma Bendamustine, Obinutuzumab
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Obinutuzumab, Prednisolone, Vincristine
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Obinutuzumab, Prednisolone, Vincristine
HSE (1) BCR::ABL1, CD20 + Acute Lymphoid Leukemia Daunorubicin, Dexamethasone, Imatinib, Methotrexate, Rituximab, Vincristine
HSE (1) CD20 + Acute Lymphoid Leukemia Daunorubicin, Dexamethasone, Methotrexate, Rituximab, Vincristine